openPR Logo
Press release

Melanoma Treatment Market – Global Industry Insights, 2025

09-22-2017 05:09 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Melanoma Treatment Market – Global Industry Insights, 2025

Melanoma is a type of skin cancer that develops from the pigment cells known as melanocytes. It is caused due to high exposure to ultraviolet rays, which leads to sunburn, especially at high altitudes. Melanoma is categorized into three: cutaneous, mucosal, and ocular. Cutaneous affects the skin, mucosal affects the mucous membrane in the mouth and nasal passage, and ocular affects the eye. However, early detection of melanoma helps in the treatment and increase survival rates. According to the American Academy of Dermatology 2015 report, the prevalence of melanoma is increasing and spreads to other body parts as well. As it spreads to other body parts, its treatment becomes much more complex. The rare genetic conditions such as xeroderma pigmentosum also increase the risk of melanoma and it is diagnosed with the biopsy of any skin lesion.

Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/719

Melanoma Treatment Market Taxonomy:

The global melanoma treatment market is segmented as follows;

By Melanoma Type;

Cutaneous Melanoma
Mucosal Melanoma
Ocular Melanoma
By Therapy;

Chemotherapy
Immunotherapy
Targeted Therapy
Surgical Treatment
Pharmacological Treatment
Development of new drugs fuels the melanoma treatment market

Several drugs in the market have already received FDA approval for melanoma treatment and some are under development. Drugs such as seviprotimut-L by Polynoma’s, talimogene laherparepvec (T-VEC) by Amgen Inc., and zelboraf, by Roche and Genetech together for the treatment of cutaneous melanoma are under development. Selumetinib is under development by AstraZeneca for the treatment of ocular melanoma. In 2011, Yervoy, a monoclonal antibody drug was developed by Bristol-Myers Squibb for the treatment of melanoma and it is the first drug to receive FDA approval. Immunotherapy drugs include opdivo and keytruda, which got FDA approval and created new opportunities in melanoma treatment market. When chemotherapy fails to deliver results, targeted therapy is used, which include BRAF inhibitors. Targeted therapy has limited side effects in comparison with chemotherapy. According to Cancer Research Institute, in 2016, there were around 76,000 people diagnosed with melanoma in the U.S. The development of novel drugs and combination therapy with limited side effects and better survival rates is expected to fuel the melanoma treatment market growth. The increased focus on personalized medicine with a huge investment in anti-melanoma drugs is expected to create new opportunities in near future. However, high price of combination therapies and clinical trial with side effects act as restraints for the melanoma treatment market.

Developed regions support the growth of melanoma treatment market

Melanoma treatment market, based on geography, is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the melanoma treatment market due to the high prevalence of melanoma in the region along with well-developed healthcare facilities and increased research and development on melanoma drugs. Moreover, reimbursement policy and increase in per capita income are expected to fuel the melanoma treatment market. Europe is the second largest market and is expected to grow significantly in near future due to increase in melanoma cases and development of novel therapies. Asia Pacific is expected to exhibit moderate growth due to fewer cases of skin cancer, lack of awareness, and high cost of melanoma drugs.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/melanoma-treatment-market-719

Key Players in the Global Melanoma Treatment Market

Some of the key players identified across the value chain of global melanoma treatment market are Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Genetech Inc., Novartis AG, Polynoma LLC, AstraZeneca, Amgen Inc., Sanofi, Merck & Co. Inc., and Takeda Pharmaceutical Company.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit Coherent Market Insights Blog @ https://blog.coherentmarketinsights.com/
Connect with us on LinkedIn @ https://www.linkedin.com/company/coherent-market-insights

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Melanoma Treatment Market – Global Industry Insights, 2025 here

News-ID: 735397 • Views: 408

More Releases from Coherent Market Insights

Volatile Corrosion Inhibitors (VCI) Packaging Material Market Growth Analysis: 2 …
Description New Research Study ❝Volatile Corrosion Inhibitors (VCI) Packaging Material Market 2023 Analysis by Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, and Investment Opportunities), Size, Share, and Outlook❝ has been added to Coherent Market insight As the operating environment becomes more complex, global organizations must continually adopt innovative business strategies. This, in turn, has created a growing demand for consulting services that align with these strategies. Every industry can benefit from transforming
Radial Compression Devices Market | Coherent Market Insights: A Report on the La …
"Coherent Market Insights offers a 45% discount on Radial Compression Devices Market Reports on Single User Access and Unlimited User Access" The Radial Compression Devices Market research report covers the current scenario and the growth prospects of the global Radial Compression Devices industry forecast 2022 - 2030. The report enlists several important factors, starting from the basics principal to advanced market intelligence which play a vital part in strategizing. Radial Compression
Atmospheric Foam Packaging Market To Boost Tremendous Growth by 2030, Business S …
Description New Research Study ❝Atmospheric Foam Packaging Market 2023 Analysis by Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, and Investment Opportunities), Size, Share, and Outlook❝ has been added to Coherent Market insight As the operating environment becomes more complex, global organizations must continually adopt innovative business strategies. This, in turn, has created a growing demand for consulting services that align with these strategies. Every industry can benefit from transforming its functional areas,
Cell Culture Market Future Business Opportunities 2023-2030 | Corning Incorporat …
"Coherent Market Insights offers Up To 45% discount on Cell Culture Market Reports on Single User Access and Unlimited User Access" The new report from Coherent Market Insights, titled "Cell Culture Market Size, Share, Price, Trends, Growth, Report and Forecast 2023-2030," offers a detailed analysis of the Cell Culture market. The report evaluates the market based on demand, application information, price trends, historical and projected market data, and company shares of the

All 5 Releases


More Releases for Melanoma

Global Melanoma Drugs Market Insights, Forecast
Melanoma is the type of cancer, in which the normal melanin-producing cells called melanocytes are turned into cancerous cells. Melanoma is usually, but not always cancer of the skin and is the most dangerous type of cancer. Mutation in melanin-producing melanocytes leads to uncontrolled division of cells forming the malignant tumor. Mainly there are three general categories of melanoma as Cutaneous, mucosal and ocular. Cutaneous melanoma is melanoma of the
Global Drugs for Melanoma Market Insights, Forecast
Melanoma is the type of cancer, in which the normal melanin-producing cells called melanocytes are turned into cancerous cells. Melanoma is usually, but not always cancer of the skin and is the most dangerous type of cancer. Mutation in melanin-producing melanocytes leads to uncontrolled division of cells forming the malignant tumor. Mainly there are three general categories of melanoma as Cutaneous, mucosal and ocular. Cutaneous melanoma is melanoma of the
Intraocular Melanoma Treatment Market Drivers
Neurological disorder diagnostics tools are medical devices, which are used in diagnosis of various neurological disorders such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and Multiple Sclerosis. The devices which are majorly used in diagnosis are imaging tools such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and in-vitro diagnostics tools such as biomarker and biopsy. Increasing prevalence of neurological disorders in the recent past has increased demand for diagnostic
Europe and Israel Mobile Applications for Melanoma Detection Market: Rising prev …
According to the TMR report, the Europe mobile applications for melanoma detection market could collect a larger revenue of around US$1.5 mn by the end of 2022. Even though Greece is dealing with economic volatility, it has been prognosticated to exhibit a perpetually elevating growth until the same year. Rise in Mortality Rate and Melanoma Incidence Puts Heavy Influence on Early Diagnosis Europe and Israel mobile applications for melanoma detection market has
Malignant Melanoma Drug Market Malignant Melanoma Clinical Pipeline Report
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Malignant Melanoma 2. Malignant Melanoma Drug Mechanism of Action 3. Global Malignant Melanoma Market Analysis 3.1 Current Market Scenario 3.2 Global Malignant Melanoma Pipeline Overview 4. Global Malignant Melanoma Drug Market Dynamics 4.1 Favorable Market Parameters 4.2 Commercialization Challenges 5. Global Malignant Melanoma Drug Market Future Prospects 6. Global Malignant Melanoma Clinical Pipeline By
Uveal Melanoma Market Information - Forecast To 2024
Global Uveal Melanom Market: Overview Uvea is present posterior to sclera and the cornea and has three parts namely, iris, ciliary body and choroid. Uveal melanoma is referred as the cancer of the parts of eye including the iris choroid and ciliray body. It is the condition in which the tumors arise from the melanocytes residing within the uva responsible for the color of the eye. Though is a rare